Gpt Alanine Transaminase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Gpt Alanine Transaminase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Alanine Transaminase | |
|---|---|
| Gene Symbol | GPT |
| Full Name | Alanine Transaminase |
| Chromosome | 8q24.3 |
| NCBI Gene ID | 2595 |
| OMIM | 613208 |
| Ensembl ID | ENSG00000149806 |
| UniProt ID | P24259 |
| Associated Diseases | Liver Disease, Metabolic Syndrome, Alzheimer's Disease |
GPT (Alanine Aminotransferase, ALT) is an enzyme that catalyzes the reversible transfer of amino groups between alanine and glutamate. It is a key marker of liver function and is important for amino acid metabolism[^1].
GPT is an aminotransferase:
GPT performs metabolic functions:
GPT is a key marker:
GPT is expressed in:
In the brain, GPT is expressed at low levels.
Gpt Alanine Transaminase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Gpt Alanine Transaminase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.